Table of Content

1 Report Overview
1.1 Pyelonephritis Drug Definition
1.2 Market by Type
1.2.1 Global Pyelonephritis Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Finafloxacin
1.2.3 Fosfomycin Tromethamine
1.2.4 Nacubactam
1.2.5 Plazomicin Sulfate
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Pyelonephritis Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Pyelonephritis Drug Sales
2.1 Global Pyelonephritis Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Pyelonephritis Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Pyelonephritis Drug Revenue by Region
2.3.1 Global Pyelonephritis Drug Revenue by Region (2018-2023)
2.3.2 Global Pyelonephritis Drug Revenue by Region (2024-2034)
2.4 Global Pyelonephritis Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Pyelonephritis Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Pyelonephritis Drug Sales Quantity by Region
2.6.1 Global Pyelonephritis Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Pyelonephritis Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Pyelonephritis Drug Sales Quantity by Manufacturers
3.1.1 Global Pyelonephritis Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Pyelonephritis Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Pyelonephritis Drug Sales in 2024
3.2 Global Pyelonephritis Drug Revenue by Manufacturers
3.2.1 Global Pyelonephritis Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Pyelonephritis Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Pyelonephritis Drug Revenue in 2024
3.3 Global Pyelonephritis Drug Sales Price by Manufacturers
3.4 Global Key Players of Pyelonephritis Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pyelonephritis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pyelonephritis Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pyelonephritis Drug, Product Offered and Application
3.8 Global Key Manufacturers of Pyelonephritis Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Pyelonephritis Drug Sales Quantity by Type
4.1.1 Global Pyelonephritis Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Pyelonephritis Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Pyelonephritis Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Pyelonephritis Drug Revenue by Type
4.2.1 Global Pyelonephritis Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Pyelonephritis Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Pyelonephritis Drug Revenue Market Share by Type (2018-2034)
4.3 Global Pyelonephritis Drug Price by Type
4.3.1 Global Pyelonephritis Drug Price by Type (2018-2023)
4.3.2 Global Pyelonephritis Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Pyelonephritis Drug Sales Quantity by Application
5.1.1 Global Pyelonephritis Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Pyelonephritis Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Pyelonephritis Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Pyelonephritis Drug Revenue by Application
5.2.1 Global Pyelonephritis Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Pyelonephritis Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Pyelonephritis Drug Revenue Market Share by Application (2018-2034)
5.3 Global Pyelonephritis Drug Price by Application
5.3.1 Global Pyelonephritis Drug Price by Application (2018-2023)
5.3.2 Global Pyelonephritis Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Pyelonephritis Drug Sales by Company
6.1.1 North America Pyelonephritis Drug Revenue by Company (2018-2023)
6.1.2 North America Pyelonephritis Drug Sales Quantity by Company (2018-2023)
6.2 North America Pyelonephritis Drug Market Size by Type
6.2.1 North America Pyelonephritis Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Pyelonephritis Drug Revenue by Type (2018-2034)
6.3 North America Pyelonephritis Drug Market Size by Application
6.3.1 North America Pyelonephritis Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Pyelonephritis Drug Revenue by Application (2018-2034)
6.4 North America Pyelonephritis Drug Market Size by Country
6.4.1 North America Pyelonephritis Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Pyelonephritis Drug Revenue by Country (2018-2034)
6.4.3 North America Pyelonephritis Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pyelonephritis Drug Sales by Company
7.1.1 Europe Pyelonephritis Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Pyelonephritis Drug Revenue by Company (2018-2023)
7.2 Europe Pyelonephritis Drug Market Size by Type
7.2.1 Europe Pyelonephritis Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Pyelonephritis Drug Revenue by Type (2018-2034)
7.3 Europe Pyelonephritis Drug Market Size by Application
7.3.1 Europe Pyelonephritis Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Pyelonephritis Drug Revenue by Application (2018-2034)
7.4 Europe Pyelonephritis Drug Market Size by Country
7.4.1 Europe Pyelonephritis Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Pyelonephritis Drug Revenue by Country (2018-2034)
7.4.3 Europe Pyelonephritis Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Pyelonephritis Drug Sales by Company
8.1.1 China Pyelonephritis Drug Sales Quantity by Company (2018-2023)
8.1.2 China Pyelonephritis Drug Revenue by Company (2018-2023)
8.2 China Pyelonephritis Drug Market Size by Type
8.2.1 China Pyelonephritis Drug Sales Quantity by Type (2018-2034)
8.2.2 China Pyelonephritis Drug Revenue by Type (2018-2034)
8.3 China Pyelonephritis Drug Market Size by Application
8.3.1 China Pyelonephritis Drug Sales Quantity by Application (2018-2034)
8.3.2 China Pyelonephritis Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Pyelonephritis Drug Sales by Company
9.1.1 APAC Pyelonephritis Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Pyelonephritis Drug Revenue by Company (2018-2023)
9.2 APAC Pyelonephritis Drug Market Size by Type
9.2.1 APAC Pyelonephritis Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Pyelonephritis Drug Revenue by Type (2018-2034)
9.3 APAC Pyelonephritis Drug Market Size by Application
9.3.1 APAC Pyelonephritis Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Pyelonephritis Drug Revenue by Application (2018-2034)
9.4 APAC Pyelonephritis Drug Market Size by Region
9.4.1 APAC Pyelonephritis Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Pyelonephritis Drug Revenue by Region (2018-2034)
9.4.3 APAC Pyelonephritis Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pyelonephritis Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Pyelonephritis Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Pyelonephritis Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Pyelonephritis Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Pyelonephritis Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Pyelonephritis Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Pyelonephritis Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Pyelonephritis Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Pyelonephritis Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Achaogen Inc
11.1.1 Achaogen Inc Company Information
11.1.2 Achaogen Inc Overview
11.1.3 Achaogen Inc Pyelonephritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Achaogen Inc Pyelonephritis Drug Products and Services
11.1.5 Achaogen Inc Pyelonephritis Drug SWOT Analysis
11.1.6 Achaogen Inc Recent Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Information
11.2.2 AstraZeneca Plc Overview
11.2.3 AstraZeneca Plc Pyelonephritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 AstraZeneca Plc Pyelonephritis Drug Products and Services
11.2.5 AstraZeneca Plc Pyelonephritis Drug SWOT Analysis
11.2.6 AstraZeneca Plc Recent Developments
11.3 Meiji Seika Pharma Co Ltd
11.3.1 Meiji Seika Pharma Co Ltd Company Information
11.3.2 Meiji Seika Pharma Co Ltd Overview
11.3.3 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Products and Services
11.3.5 Meiji Seika Pharma Co Ltd Pyelonephritis Drug SWOT Analysis
11.3.6 Meiji Seika Pharma Co Ltd Recent Developments
11.4 Merck & Co Inc
11.4.1 Merck & Co Inc Company Information
11.4.2 Merck & Co Inc Overview
11.4.3 Merck & Co Inc Pyelonephritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Merck & Co Inc Pyelonephritis Drug Products and Services
11.4.5 Merck & Co Inc Pyelonephritis Drug SWOT Analysis
11.4.6 Merck & Co Inc Recent Developments
11.5 MerLion Pharmaceuticals Pte Ltd
11.5.1 MerLion Pharmaceuticals Pte Ltd Company Information
11.5.2 MerLion Pharmaceuticals Pte Ltd Overview
11.5.3 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Products and Services
11.5.5 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug SWOT Analysis
11.5.6 MerLion Pharmaceuticals Pte Ltd Recent Developments
11.6 The Medicines Company
11.6.1 The Medicines Company Company Information
11.6.2 The Medicines Company Overview
11.6.3 The Medicines Company Pyelonephritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 The Medicines Company Pyelonephritis Drug Products and Services
11.6.5 The Medicines Company Pyelonephritis Drug SWOT Analysis
11.6.6 The Medicines Company Recent Developments
11.7 Zavante Therapeutics Inc
11.7.1 Zavante Therapeutics Inc Company Information
11.7.2 Zavante Therapeutics Inc Overview
11.7.3 Zavante Therapeutics Inc Pyelonephritis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Zavante Therapeutics Inc Pyelonephritis Drug Products and Services
11.7.5 Zavante Therapeutics Inc Pyelonephritis Drug SWOT Analysis
11.7.6 Zavante Therapeutics Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pyelonephritis Drug Value Chain Analysis
12.2 Pyelonephritis Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pyelonephritis Drug Production Mode & Process
12.4 Pyelonephritis Drug Sales and Marketing
12.4.1 Pyelonephritis Drug Sales Channels
12.4.2 Pyelonephritis Drug Distributors
12.5 Pyelonephritis Drug Customers
13 Market Dynamics
13.1 Pyelonephritis Drug Industry Trends
13.2 Pyelonephritis Drug Market Drivers
13.3 Pyelonephritis Drug Market Challenges
13.4 Pyelonephritis Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Pyelonephritis Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Finafloxacin
Table 3. Major Manufacturers of Fosfomycin Tromethamine
Table 4. Major Manufacturers of Nacubactam
Table 5. Major Manufacturers of Plazomicin Sulfate
Table 6. Major Manufacturers of Others
Table 7. Global Pyelonephritis Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Pyelonephritis Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Pyelonephritis Drug Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Pyelonephritis Drug Revenue Market Share by Region (2018-2023)
Table 11. Global Pyelonephritis Drug Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Pyelonephritis Drug Revenue Market Share by Region (2024-2034)
Table 13. Global Pyelonephritis Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 14. Global Pyelonephritis Drug Sales by Region (2018-2023) & (K Pcs)
Table 15. Global Pyelonephritis Drug Sales Market Share by Region (2018-2023)
Table 16. Global Pyelonephritis Drug Sales by Region (2024-2034) & (K Pcs)
Table 17. Global Pyelonephritis Drug Sales Market Share by Region (2024-2034)
Table 18. Global Pyelonephritis Drug Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 19. Global Pyelonephritis Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Pyelonephritis Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Pyelonephritis Drug Revenue Share by Manufacturers (2018-2023)
Table 22. Global Pyelonephritis Drug Price by Manufacturers 2018-2023 (USD/Pcs)
Table 23. Global Key Players of Pyelonephritis Drug, Industry Ranking, 2021 VS 2024
Table 24. Global Pyelonephritis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Pyelonephritis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pyelonephritis Drug as of 2024)
Table 26. Global Key Manufacturers of Pyelonephritis Drug, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Pyelonephritis Drug, Product Offered and Application
Table 28. Global Key Manufacturers of Pyelonephritis Drug, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Pyelonephritis Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 31. Global Pyelonephritis Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 32. Global Pyelonephritis Drug Sales Quantity Share by Type (2018-2023)
Table 33. Global Pyelonephritis Drug Sales Quantity Share by Type (2024-2034)
Table 34. Global Pyelonephritis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Pyelonephritis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Pyelonephritis Drug Revenue Share by Type (2018-2023)
Table 37. Global Pyelonephritis Drug Revenue Share by Type (2024-2034)
Table 38. Pyelonephritis Drug Price by Type (2018-2023) & (USD/Pcs)
Table 39. Global Pyelonephritis Drug Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 40. Global Pyelonephritis Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 41. Global Pyelonephritis Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 42. Global Pyelonephritis Drug Sales Quantity Share by Application (2018-2023)
Table 43. Global Pyelonephritis Drug Sales Quantity Share by Application (2024-2034)
Table 44. Global Pyelonephritis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Pyelonephritis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Pyelonephritis Drug Revenue Share by Application (2018-2023)
Table 47. Global Pyelonephritis Drug Revenue Share by Application (2024-2034)
Table 48. Pyelonephritis Drug Price by Application (2018-2023) & (USD/Pcs)
Table 49. Global Pyelonephritis Drug Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 50. North America Pyelonephritis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Pyelonephritis Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 52. North America Pyelonephritis Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 53. North America Pyelonephritis Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 54. North America Pyelonephritis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Pyelonephritis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Pyelonephritis Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 57. North America Pyelonephritis Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 58. North America Pyelonephritis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Pyelonephritis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Pyelonephritis Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Pyelonephritis Drug Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Pyelonephritis Drug Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Pyelonephritis Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 64. North America Pyelonephritis Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 65. Europe Pyelonephritis Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 66. Europe Pyelonephritis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Pyelonephritis Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 68. Europe Pyelonephritis Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 69. Europe Pyelonephritis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Pyelonephritis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Pyelonephritis Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 72. Europe Pyelonephritis Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 73. Europe Pyelonephritis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Pyelonephritis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Pyelonephritis Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Pyelonephritis Drug Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Pyelonephritis Drug Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Pyelonephritis Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 79. Europe Pyelonephritis Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 80. China Pyelonephritis Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 81. China Pyelonephritis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Pyelonephritis Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 83. China Pyelonephritis Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 84. China Pyelonephritis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Pyelonephritis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Pyelonephritis Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 87. China Pyelonephritis Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 88. China Pyelonephritis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Pyelonephritis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Pyelonephritis Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 91. APAC Pyelonephritis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Pyelonephritis Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 93. APAC Pyelonephritis Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 94. APAC Pyelonephritis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Pyelonephritis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Pyelonephritis Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 97. APAC Pyelonephritis Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 98. APAC Pyelonephritis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Pyelonephritis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Pyelonephritis Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Pyelonephritis Drug Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Pyelonephritis Drug Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Pyelonephritis Drug Sales Quantity by Region (2018-2023) & (K Pcs)
Table 104. APAC Pyelonephritis Drug Sales Quantity by Region (2024-2034) & (K Pcs)
Table 105. Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 106. Middle East, Africa and Latin America Pyelonephritis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 108. Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 109. Middle East, Africa and Latin America Pyelonephritis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Pyelonephritis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 112. Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 113. Middle East, Africa and Latin America Pyelonephritis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Pyelonephritis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Pyelonephritis Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Pyelonephritis Drug Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Pyelonephritis Drug Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 119. Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 120. Achaogen Inc Company Information
Table 121. Achaogen Inc Description and Overview
Table 122. Achaogen Inc Pyelonephritis Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 123. Achaogen Inc Pyelonephritis Drug Product and Services
Table 124. Achaogen Inc Pyelonephritis Drug SWOT Analysis
Table 125. Achaogen Inc Recent Developments
Table 126. AstraZeneca Plc Company Information
Table 127. AstraZeneca Plc Description and Overview
Table 128. AstraZeneca Plc Pyelonephritis Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 129. AstraZeneca Plc Pyelonephritis Drug Product and Services
Table 130. AstraZeneca Plc Pyelonephritis Drug SWOT Analysis
Table 131. AstraZeneca Plc Recent Developments
Table 132. Meiji Seika Pharma Co Ltd Company Information
Table 133. Meiji Seika Pharma Co Ltd Description and Overview
Table 134. Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 135. Meiji Seika Pharma Co Ltd Pyelonephritis Drug Product and Services
Table 136. Meiji Seika Pharma Co Ltd Pyelonephritis Drug SWOT Analysis
Table 137. Meiji Seika Pharma Co Ltd Recent Developments
Table 138. Merck & Co Inc Company Information
Table 139. Merck & Co Inc Description and Overview
Table 140. Merck & Co Inc Pyelonephritis Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 141. Merck & Co Inc Pyelonephritis Drug Product and Services
Table 142. Merck & Co Inc Pyelonephritis Drug SWOT Analysis
Table 143. Merck & Co Inc Recent Developments
Table 144. MerLion Pharmaceuticals Pte Ltd Company Information
Table 145. MerLion Pharmaceuticals Pte Ltd Description and Overview
Table 146. MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 147. MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Product and Services
Table 148. MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug SWOT Analysis
Table 149. MerLion Pharmaceuticals Pte Ltd Recent Developments
Table 150. The Medicines Company Company Information
Table 151. The Medicines Company Description and Overview
Table 152. The Medicines Company Pyelonephritis Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 153. The Medicines Company Pyelonephritis Drug Product and Services
Table 154. The Medicines Company Pyelonephritis Drug SWOT Analysis
Table 155. The Medicines Company Recent Developments
Table 156. Zavante Therapeutics Inc Company Information
Table 157. Zavante Therapeutics Inc Description and Overview
Table 158. Zavante Therapeutics Inc Pyelonephritis Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 159. Zavante Therapeutics Inc Pyelonephritis Drug Product and Services
Table 160. Zavante Therapeutics Inc Pyelonephritis Drug SWOT Analysis
Table 161. Zavante Therapeutics Inc Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Pyelonephritis Drug Distributors List
Table 165. Pyelonephritis Drug Customers List
Table 166. Pyelonephritis Drug Market Trends
Table 167. Pyelonephritis Drug Market Drivers
Table 168. Pyelonephritis Drug Market Challenges
Table 169. Pyelonephritis Drug Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Pyelonephritis Drug Product Picture
Figure 2. Global Pyelonephritis Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Pyelonephritis Drug Market Share by Type in 2024 & 2034
Figure 4. Finafloxacin Product Picture
Figure 5. Fosfomycin Tromethamine Product Picture
Figure 6. Nacubactam Product Picture
Figure 7. Plazomicin Sulfate Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pyelonephritis Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Pyelonephritis Drug Market Share by Application in 2024 & 2034
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Others
Figure 14. Pyelonephritis Drug Report Years Considered
Figure 15. Global Pyelonephritis Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Pyelonephritis Drug Revenue 2018-2034 (US$ Million)
Figure 17. Global Pyelonephritis Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 18. Global Pyelonephritis Drug Sales Quantity 2018-2034 (K Pcs)
Figure 19. Global Pyelonephritis Drug Sales Quantity Market Share by Region (2018-2023)
Figure 20. Global Pyelonephritis Drug Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Pyelonephritis Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 22. North America Pyelonephritis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Pyelonephritis Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. Europe Pyelonephritis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Pyelonephritis Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. China Pyelonephritis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Pyelonephritis Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. APAC Pyelonephritis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. Middle East, Africa and Latin America Pyelonephritis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Pyelonephritis Drug Sales Quantity in 2024
Figure 32. The Top 10 and Top 5 Players Market Share by Pyelonephritis Drug Revenue in 2024
Figure 33. Pyelonephritis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 34. Global Pyelonephritis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Pyelonephritis Drug Revenue Market Share by Type (2018-2034)
Figure 36. Global Pyelonephritis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Pyelonephritis Drug Revenue Market Share by Application (2018-2034)
Figure 38. North America Pyelonephritis Drug Revenue Market Share by Company in 2024
Figure 39. North America Pyelonephritis Drug Sales Quantity Market Share by Company in 2024
Figure 40. North America Pyelonephritis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Pyelonephritis Drug Revenue Market Share by Type (2018-2034)
Figure 42. North America Pyelonephritis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Pyelonephritis Drug Revenue Market Share by Application (2018-2034)
Figure 44. North America Pyelonephritis Drug Revenue Share by Country (2018-2034)
Figure 45. North America Pyelonephritis Drug Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Pyelonephritis Drug Sales Quantity Market Share by Company in 2024
Figure 49. Europe Pyelonephritis Drug Revenue Market Share by Company in 2024
Figure 50. Europe Pyelonephritis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Pyelonephritis Drug Revenue Market Share by Type (2018-2034)
Figure 52. Europe Pyelonephritis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Pyelonephritis Drug Revenue Market Share by Application (2018-2034)
Figure 54. Europe Pyelonephritis Drug Revenue Share by Country (2018-2034)
Figure 55. Europe Pyelonephritis Drug Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 57. France Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 61. China Pyelonephritis Drug Sales Quantity Market Share by Company in 2024
Figure 62. China Pyelonephritis Drug Revenue Market Share by Company in 2024
Figure 63. China Pyelonephritis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Pyelonephritis Drug Revenue Market Share by Type (2018-2034)
Figure 65. China Pyelonephritis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Pyelonephritis Drug Revenue Market Share by Application (2018-2034)
Figure 67. APAC Pyelonephritis Drug Sales Quantity Market Share by Company in 2024
Figure 68. APAC Pyelonephritis Drug Revenue Market Share by Company in 2024
Figure 69. APAC Pyelonephritis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Pyelonephritis Drug Revenue Market Share by Type (2018-2034)
Figure 71. APAC Pyelonephritis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Pyelonephritis Drug Revenue Market Share by Application (2018-2034)
Figure 73. APAC Pyelonephritis Drug Revenue Share by Region (2018-2034)
Figure 74. APAC Pyelonephritis Drug Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 79. India Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Pyelonephritis Drug Revenue Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Pyelonephritis Drug Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Pyelonephritis Drug Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Pyelonephritis Drug Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Pyelonephritis Drug Revenue Share by Country (2018-2034)
Figure 88. Brazil Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Pyelonephritis Drug Revenue (2018-2034) & (US$ Million)
Figure 93. Pyelonephritis Drug Value Chain
Figure 94. Pyelonephritis Drug Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed